| Heading: |
Respiratory Syncytial Virus: Vaccination |
| Question ID: |
1811363 |
| UIN: |
HL8325 |
| House: |
Lords |
| Date tabled: |
2025-06-10 |
| Asking Member ID: |
4130 |
| Asking Member display name: |
Baroness Ritchie of Downpatrick
|
| Asking Member handle: |
MRitchieSD
|
| Asking Member Twitter reference: |
@MRitchieSD
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government whether they will make an assessment of the potential merits of extending the eligibility for the respiratory syncytial virus vaccination to include people aged over 80, clinical risk groups, and immunocompromised populatio |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-24 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
During the Joint Committee on Vaccination and Immunisation (JCVI) meeting of 5 February 2025, the Department confirmed that any extension to the respiratory syncytial virus (RSV) vaccination programme, including to those aged 80 years old and above as wel... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |